dalteparin has been researched along with Neoplasms, Vascular in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Vascular leiomyosarcomas are extremely rare tumors and represent only 0." | 2.45 | Peripheral artery leiomyosarcoma. ( Babel, N; Chamberlain, RS; Mehta, R; Sakpal, SV, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garcipérez de Vargas, FJ | 1 |
Marcos, G | 1 |
Moyano Calvente, SL | 1 |
Sakpal, SV | 1 |
Mehta, R | 1 |
Babel, N | 1 |
Chamberlain, RS | 1 |
1 review available for dalteparin and Neoplasms, Vascular
Article | Year |
---|---|
Peripheral artery leiomyosarcoma.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Biopsy; Enoxaparin; Female; Femoral Artery; Humans; | 2009 |
1 other study available for dalteparin and Neoplasms, Vascular
Article | Year |
---|---|
Pulmonary embolism as a first manifestation of intracardiac extension of an endometrial stromal sarcoma.
Topics: Anticoagulants; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; E | 2014 |